"Ozempic: Quieting Loud Desires"

A study conducted by Marco Leyton, PhD, at McGill University in Canada, involving cocaine and a special protein shake, revealed that a lack of phenylalanine in the shake decreased participants' craving for cocaine without affecting the drug's euphoric effects. This sheds light on the brain's wanting system and the distinction between liking and wanting. GLP-1 drugs, primarily used for diabetes and weight loss, are showing potential in reducing cravings for substances like alcohol, nicotine, and opioids by tapping into the brain's reward system. These drugs seem to quiet the wanting mind while leaving liking intact, offering hope for addressing addiction and overeating.